By Jess Jones UK health tech company Tagomics has raised £6.7m in funding as it looks to ramp up its research efforts and develop its platform which diagnoses and treats diseases, including cancer. The funding round, led by Calculus Capital, will enable Tagomics to discover new signs of cancer and advance drug development and therapy selection for patients. Other investors include Illumina Ventures, IQ Capital, Agilent Ventures, Mercia Ventures and the MEIF Proof of Concept & Early Stage Fund, which is managed by Mercia Ventures and is part of the Midlands Engine Investment Fund (MEIF). It fol…